Shanghai Kehua Bio-engineering Co., Ltd (KHB) was founded in 1981, focusing on the IVD business. In July 2004, KHB listed on the Shen Zhen Stock Exchange and is now one of the largest developers, manufacturers and marketers of in vitro diagnostic products in China. offering products mainly in three primary business segments: Diagnostic Reagents, Diagnostic Laboratory Instruments, and Evacuated Receptacles.

Based on the innovation center and the post-doctoral workstation with excellent R&D professionals and talents, we have built a world-class R&D platform. We have successfully broadened our market reach by introducing more advanced products and new product lines that address different end-user segments. To date, KHB has obtained registration certificates (SFDA) for100-plus products and 60 have been CE-marked.

Supported by the highly effective sales networks with 700 more distributors in China and 38 more overseas, we believe most of our key IVD products are keeping the leading market position in China and have a significant and growing international presence with the success of the global market penetration. In particular, we are one of the global suppliers of WHO,UNICEF,PEPFAR and Clinton HIV/AIDS Initiative.

We have a proven rapid growth in the past two decades. In the future, KHB will continue to provide high quality, competitive priced IVD products and services to our customers for the benefit of the world.

KHB profile-EN-2014